This document discusses the private payer market for prescription drugs in Canada. It provides data on prescription drug spending by payer type across different Canadian regions in 2014. The private market accounts for 22-48% of drug spending across regions. The document also outlines the drug development, review, pricing and reimbursement process in Canada as well as the role of private drug plans and provincial plans. It notes that employer drug plans are important since diseases can impact productivity at work both physically and mentally.